Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$39.16+1.48 (+3.93%)
Close on Nov 18, 2026Market cap $51.48BP/E –Yield –
Medline revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Medline's revenue for the twelve months ending Sep 26, 2026 was $30.68B. For fiscal 2025 it was $28.43B, up 11.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.43B | +11.5% |
| FY2024 | Dec 31, 2024 | $25.51B | +9.8% |
| FY2023 | Dec 31, 2023 | $23.23B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $7.86B | +10.4% |
| Q2 FY2026 | Jun 27, 2026 | $7.69B | +11.6% |
| Q1 FY2026 | Mar 28, 2026 | $7.35B | +10.7% |
| Q4 FY2025 | Dec 31, 2025 | $7.79B | – |
| Q3 FY2025 | Sep 27, 2025 | $7.12B | – |
| Q2 FY2025 | Jun 28, 2025 | $6.89B | – |
| Q1 FY2025 | Mar 29, 2025 | $6.64B | – |
See a number that looks wrong?